Azin Parhizgar, PhD

Dr. Azin Parhizgar is a highly accomplished medical device executive, a serial entrepreneur, and a seasoned Medtech investor. Currently Dr. Parhizgar is the Managing Director at 415 Capital Management GmbH, a cardio- neurovascular focused early-stage venture investment fund, Chairwoman of the board of CVPath Institute, Inc. as well as Protembis GmbH, and serves as an independent director at CroiValve, InnovHeart s.r.l, and Women As One, among other held positions. In her five-year tenure as the President and CEO of Claret Medical, an embolic protection company, Dr. Parhizgar led the venture-backed company to a successful global commercial launch with a subsequent acquisition in 2018 by Boston Scientific, Inc.  Prior to Claret Medical, she was the President and COO of Conor Medsystems, a drug eluting Stent Company acquired by Johnson & Johnson, Inc. in 2007. Prior to Conor Medsystems Dr. Parhizgar was Executive Global Vice President at Arterial Vascular Engineering (AVE), which was acquired by Medtronic Inc. in 2000. Dr. Parhizgar earned both her Ph.D. in Cell, Gene and Tissue Engineering and her M.Sc. in Biomechanical Engineering and Artificial Organ Design from Brown University in Providence, RI, USA.